Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen Add-on for GERD Symptoms
NCT07063576Phase 3Recruiting
- Start
- Aug 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baclofen in gastroesophageal reflux disease (GERD). Started Aug 2025; status: recruiting.
02
Drugs
baclofen
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT07063576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07063576.